LMOD2
Leiomodin-2
Also known as: LMOD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P5Q4
- Gene
- LMOD2
- Ensembl
- ENSG00000170807
- Chromosome
- 7
- Canonical length
- 547 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Actin filaments,Cytosol
OverviewNCBI Gene
Enables actin monomer binding activity and tropomyosin binding activity. Involved in actin nucleation; positive regulation of actin filament polymerization; and sarcomere organization. Located in M band and actin filament. Implicated in dilated cardiomyopathy 2G. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
547 residues, UniProt reviewed canonical sequence.
>Q6P5Q4|LMOD2
1 MSTFGYRRGL SKYESIDEDE LLASLSAEEL KELERELEDI EPDRNLPVGL RQKSLTEKTP
61 TGTFSREALM AYWEKESQKL LEKERLGECG KVAEDKEESE EELIFTESNS EVSEEVYTEE
121 EEEESQEEEE EEDSDEEERT IETAKGINGT VNYDSVNSDN SKPKIFKSQI ENINLTNGSN
181 GRNTESPAAI HPCGNPTVIE DALDKIKSND PDTTEVNLNN IENITTQTLT RFAEALKDNT
241 VVKTFSLANT HADDSAAMAI AEMLKVNEHI TNVNVESNFI TGKGILAIMR ALQHNTVLTE
301 LRFHNQRHIM GSQVEMEIVK LLKENTTLLR LGYHFELPGP RMSMTSILTR NMDKQRQKRL
361 QEQKQQEGYD GGPNLRTKVW QRGTPSSSPY VSPRHSPWSS PKLPKKVQTV RSRPLSPVAT
421 PPPPPPPPPP PPPSSQRLPP PPPPPPPPLP EKKLITRNIA EVIKQQESAQ RALQNGQKKK
481 KGKKVKKQPN SILKEIKNSL RSVQEKKMED SSRPSTPQRS AHENLMEAIR GSSIKQLKRV
541 EVPEALRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LMOD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 874 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 874 nTPM
- tongue: 741 nTPM
- heart muscle: 729 nTPM
- esophagus: 20 nTPM
- salivary gland: 10 nTPM
- prostate: 9.6 nTPM
Single-cell type
- thymic myoid cells: 559 nCPM
- myonuclei: 448 nCPM
- cardiomyocytes: 142 nCPM
- parietal cells: 25 nCPM
- epicardial cells: 14 nCPM
- endometrial secretory cells: 7.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.3 nTPM
- hippocampal formation: 0.9 nTPM
- choroid plexus: 0.8 nTPM
- midbrain: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- cerebellum: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LMOD2.
Disease | AllUniProt
Conditions LMOD2 is implicated in, by any mechanism.
- Cardiomyopathy, dilated, 2G (CMD2G) MIM:619897
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 101 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cardiomyopathy, dilated, 2G
- Familial isolated dilated cardiomyopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- actin filament polymerization
- actin nucleation
- muscle contraction
- myofibril assembly
- pointed-end actin filament capping
- positive regulation of actin filament polymerization
- sarcomere organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LMOD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LMOD2 as an antibody target. Whether an autoantibody or antibody against LMOD2 could matter depends on whether native LMOD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LMOD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LMOD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...